Publication Topic : Access to Medicines
Bill C-393 in the Senate: Amendments to the Patent Act (March 2011)
Bill C-393 passed with a large majority of votes in the House of Commons in Parliament on March 9, 2011 and is now before the Senate of Canada. Bill C-393 would make a number of changes to the sections of the Patent Act that currently constitute Canada’s Access to Medicines Regime (CAMR). The text below … Lire plus
Human Rights and the Global Fund to Fight AIDS, Tuberculosis and Malaria
The objective of this paper is to examine the human rights content and impact of the Global Fund’s work in three areas — grant-making processes, grants, and advocacy, especially to see how this unique institution manages the balancing act to which its principles lead. Without pretending to have conducted an exhaustive investigation, we examine some … Lire plus
Projet de loi C-393 : éléments centraux et conformité aux obligations du Canada à l’OMC (mars 2011)
D’aucuns prétendent erronément que la « solution à licence unique » que propose le Projet de loi C-393 enfreint les obligations du Canada devant l’OMC. À titre de complément au mémoire déposé plus tôt par le Réseau juridique, ce document-ci présente un sommaire des points principaux et des dispositions du droit de l’OMC qui autorisent … Lire plus
Letter to Trade Ministers re: Safeguarding Access to Medicines in the Trans-Pacific Partnership Agreement
« We, the undersigned civil society organizations, write to you regarding intellectual property provisions in the proposed Trans-Pacific Partnership Agreement (TPPA). We are concerned that intellectual property measures that may be included in an eventual agreement could undermine patients’ access to vital medicines, and contravene promises of a new trade model and ’21st century’ agreement. »